Fingerprint
Dive into the research topics of 'Phase Ia study of the indoleamine 2,3-dioxygenase 1 (IDO1) inhibitor navoximod (GDC-0919) in patients with recurrent advanced solid tumors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically